Acknowledgement
We thank K. Iwai for GST-TNFα cDNA. This work was supported by a Korea University grant (E.-J.C.).
References
- Babst, M., Odorizzi, G., Estepa, E.J., and Emr, S.D. (2000). Mammalian tumor susceptibility gene 101 (TSG101) and the yeast homologue, Vps23p, both function in late endosomal trafficking. Traffic 1, 248-258. https://doi.org/10.1034/j.1600-0854.2000.010307.x
- Elliott, P.R., Leske, D., Hrdinka, M., Bagola, K., Fiil, B.K., McLaughlin, S.H., Wagstaff, J., Volkmar, N., Christianson, J.C., Kessler, B.M., et al. (2016). SPATA2 links CYLD to LUBAC, activates CYLD, and controls LUBAC signaling. Mol. Cell 63, 990-1005. https://doi.org/10.1016/j.molcel.2016.08.001
- Elliott, P.R., Nielsen, S.V., Marco-Casanova, P., Fiil, B.K., Keusekotten, K., Mailand, N., Freund, S.M., Gyrd-Hansen, M., and Komander, D. (2014). Molecular basis and regulation of OTULIN-LUBAC interaction. Mol. Cell 54, 335-348. https://doi.org/10.1016/j.molcel.2014.03.018
- Feng, G.H., Lih, C.J., and Cohen, S.N. (2000). TSG101 protein steady-state level is regulated posttranslationally by an evolutionarily conserved COOH-terminal sequence. Cancer Res. 60, 1736-1741.
- Ferraiuolo, R.M., Manthey, K.C., Stanton, M.J., Triplett, A.A., and Wagner, K.U. (2020). The multifaceted roles of the tumor susceptibility gene 101 (TSG101) in normal development and disease. Cancers (Basel) 12, 450.
- Fujita, H., Tokunaga, A., Shimizu, S., Whiting, A.L., Aguilar-Alonso, F., Takagi, K., Walinda, E., Sasaki, Y., Shimokawa, T., Mizushima, T., et al. (2018). Cooperative domain formation by homologous motifs in HOIL-1L and SHARPIN plays a crucial role in LUBAC stabilization. Cell Rep. 23, 1192-1204. https://doi.org/10.1016/j.celrep.2018.03.112
- Gerlach, B., Cordier, S.M., Schmukle, A.C., Emmerich, C.H., Rieser, E., Haas, T.L., Webb, A.I., Rickard, J.A., Anderton, H., Wong, W.W.L., et al. (2011). Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471, 591-596. https://doi.org/10.1038/nature09816
- Haas, T.L., Emmerich, C.H., Gerlach, B., Schmukle, A.C., Cordier, S.M., Rieser, E., Feltham, R., Vince, J., Warnken, U., Wenger, T., et al. (2009). Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol. Cell 36, 831-844. https://doi.org/10.1016/j.molcel.2009.10.013
- Hsu, H., Huang, J., Shu, H.B., Baichwal, V., and Goeddel, D.V. (1996). TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4, 387-396. https://doi.org/10.1016/S1074-7613(00)80252-6
- Ikeda, F., Deribe, Y.L., Skanland, S.S., Stieglitz, B., Grabbe, C., Franz-Wachtel, M., Van Wijk, S.J., Goswami, P., Nagy, V., Terzic, J., et al. (2011). SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis. Nature 471, 637-641. https://doi.org/10.1038/nature09814
- Katzmann, D.J., Babst, M., and Emr, S.D. (2001). Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I. Cell 106, 145-155. https://doi.org/10.1016/S0092-8674(01)00434-2
- Keusekotten, K., Elliott, P.R., Glockner, L., Fiil, B.K., Damgaard, R.B., Kulathu, Y., Wauer, T., Hospenthal, M.K., Gyrd-Hansen, M., Krappmann, D., et al. (2013). OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin. Cell 153, 1312-1326. https://doi.org/10.1016/j.cell.2013.05.014
- Kirisako, T., Kamei, K., Murata, S., Kato, M., Fukumoto, H., Kanie, M., Sano, S., Tokunaga, F., Tanaka, K., and Iwai, K. (2006). A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO J. 25, 4877-4887. https://doi.org/10.1038/sj.emboj.7601360
- Koonin, E.V. and Abagyan, R.A. (1997). TSG101 may be the prototype of a class of dominant negative ubiquitin regulators. Nat. Genet. 16, 330-331. https://doi.org/10.1038/ng0897-330
- Kupka, S., De Miguel, D., Draber, P., Martino, L., Surinova, S., Rittinger, K., and Walczak, H. (2016). SPATA2-mediated binding of CYLD to HOIP enables CYLD recruitment to signaling complexes. Cell Rep. 16, 2271-2280. https://doi.org/10.1016/j.celrep.2016.07.086
- Lechtenberg, B.C., Rajput, A., Sanishvili, R., Dobaczewska, M.K., Ware, C.F., Mace, P.D., and Riedl, S.J. (2016). Structure of a HOIP/E2~ ubiquitin complex reveals RBR E3 ligase mechanism and regulation. Nature 529, 546-550. https://doi.org/10.1038/nature16511
- Lee, I.Y., Lim, J.M., Cho, H., Kim, E., Kim, Y., Oh, H.K., Yang, W.S., Roh, K.H., Park, H.W., Mo, J.S., et al. (2019). MST1 negatively regulates TNFα-induced NF-κB signaling through modulating LUBAC activity. Mol. Cell 73, 1138-1149.e6. https://doi.org/10.1016/j.molcel.2019.01.022
- Li, L. and Cohen, S.N. (1996). Tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells. Cell 85, 319-329. https://doi.org/10.1016/S0092-8674(00)81111-3
- Li, L., Liao, J., Ruland, J., Mak, T.W., and Cohen, S.N. (2001). A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control. Proc. Natl. Acad. Sci. U. S. A. 98, 1619-1624. https://doi.org/10.1073/pnas.98.4.1619
- Li, Y., Kane, T., Tipper, C., Spatrick, P., and Jenness, D.D. (1999). Yeast mutants affecting possible quality control of plasma membrane proteins. Mol. Cell. Biol. 19, 3588-3599. https://doi.org/10.1128/MCB.19.5.3588
- Liu, J., Wang, Y., Gong, Y., Fu, T., Hu, S., Zhou, Z., and Pan, L. (2017). Structural insights into SHARPIN-mediated activation of HOIP for the linear ubiquitin chain assembly. Cell Rep. 21, 27-36. https://doi.org/10.1016/j.celrep.2017.09.031
- Lu, Q., Hope, L.W., Brasch, M., Reinhard, C., and Cohen, S.N. (2003). TSG101 interaction with HRS mediates endosomal trafficking and receptor down-regulation. Proc. Natl. Acad. Sci. U. S. A. 100, 7626-7631. https://doi.org/10.1073/pnas.0932599100
- Peltzer, N., Rieser, E., Taraborrelli, L., Draber, P., Darding, M., Pernaute, B., Shimizu, Y., Sarr, A., Draberova, H., Montinaro, A., et al. (2014). HOIP deficiency causes embryonic lethality by aberrant TNFR1-mediated endothelial cell death. Cell Rep. 9, 153-165. https://doi.org/10.1016/j.celrep.2014.08.066
- Ponting, C., Cai, Y., and Bork, P. (1997). The breast cancer gene product TSG101: a regulator of ubiquitination? J. Mol. Med. (Berl.) 75, 467-469.
- Pornillos, O., Alam, S.L., Rich, R.L., Myszka, D.G., Davis, D.R., and Sundquist, W.I. (2002). Structure and functional interactions of the Tsg101 UEV domain. EMBO J. 21, 2397-2406. https://doi.org/10.1093/emboj/21.10.2397
- Rahighi, S., Ikeda, F., Kawasaki, M., Akutsu, M., Suzuki, N., Kato, R., Kensche, T., Uejima, T., Bloor, S., Komander, D., et al. (2009). Specific recognition of linear ubiquitin chains by NEMO is important for NF-κB activation. Cell 136, 1098-1109. https://doi.org/10.1016/j.cell.2009.03.007
- Rickard, J.A., Anderton, H., Etemadi, N., Nachbur, U., Darding, M., Peltzer, N., Lalaoui, N., Lawlor, K.E., Vanyai, H., Hall, C., et al. (2014). TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice. Elife 3, e03464.
- Schaeffer, V., Akutsu, M., Olma, M.H., Gomes, L.C., Kawasaki, M., and Dikic, I. (2014). Binding of OTULIN to the PUB domain of HOIP controls NF-κB signaling. Mol. Cell 54, 349-361. https://doi.org/10.1016/j.molcel.2014.03.016
- Shu, H.B., Takeuchi, M., and Goeddel, D.V. (1996). The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. Proc. Natl. Acad. Sci. U. S. A. 93, 13973-13978. https://doi.org/10.1073/pnas.93.24.13973
- Smit, J.J., Monteferrario, D., Noordermeer, S.M., Van Dijk, W.J., Van Der Reijden, B.A., and Sixma, T.K. (2012). The E3 ligase HOIP specifies linear ubiquitin chain assembly through its RING-IBR-RING domain and the unique LDD extension. EMBO J. 31, 3833-3844. https://doi.org/10.1038/emboj.2012.217
- Stieglitz, B., Morris-Davies, A.C., Koliopoulos, M.G., Christodoulou, E., and Rittinger, K. (2012). LUBAC synthesizes linear ubiquitin chains via a thioester intermediate. EMBO Rep. 13, 840-846. https://doi.org/10.1038/embor.2012.105
- Stieglitz, B., Rana, R.R., Koliopoulos, M.G., Morris-Davies, A.C., Schaeffer, V., Christodoulou, E., Howell, S., Brown, N.R., Dikic, I., and Rittinger, K. (2013). Structural basis for ligase-specific conjugation of linear ubiquitin chains by HOIP. Nature 503, 422-426. https://doi.org/10.1038/nature12638
- Takiuchi, T., Nakagawa, T., Tamiya, H., Fujita, H., Sasaki, Y., Saeki, Y., Takeda, H., Sawasaki, T., Buchberger, A., Kimura, T., et al. (2014). Suppression of LUBAC-mediated linear ubiquitination by a specific interaction between LUBAC and the deubiquitinases CYLD and OTULIN. Genes Cells 19, 254-272. https://doi.org/10.1111/gtc.12128
- Tokunaga, F., Nakagawa, T., Nakahara, M., Saeki, Y., Taniguchi, M., Sakata, S., Tanaka, K., Nakano, H., and Iwai, K. (2011). SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex. Nature 471, 633-636. https://doi.org/10.1038/nature09815
- Tokunaga, F., Sakata, S., Saeki, Y., Satomi, Y., Kirisako, T., Kamei, K., Nakagawa, T., Kato, M., Murata, S., Yamaoka, S., et al. (2009). Involvement of linear polyubiquitylation of NEMO in NF-κB activation. Nat. Cell Biol. 11, 123-132. https://doi.org/10.1038/ncb1821
- Varfolomeev, E., Goncharov, T., Fedorova, A.V., Dynek, J.N., Zobel, K., Deshayes, K., Fairbrother, W.J., and Vucic, D. (2008). c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor α (TNFα)-induced NF-κB activation. J. Biol. Chem. 283, 24295-24299. https://doi.org/10.1074/jbc.C800128200
- Vince, J.E., Pantaki, D., Feltham, R., Mace, P.D., Cordier, S.M., Schmukle, A.C., Davidson, A.J., Callus, B.A., Wong, W.W.L., Gentle, I.E., et al. (2009). TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (TNF) to efficiently activate NF-κB and to prevent TNF-induced apoptosis. J. Biol. Chem. 284, 35906-35915. https://doi.org/10.1074/jbc.M109.072256
- Wagner, S.A., Satpathy, S., Beli, P., and Choudhary, C. (2016). SPATA 2 links CYLD to the TNF-α receptor signaling complex and modulates the receptor signaling outcomes. EMBO J. 35, 1868-1884. https://doi.org/10.15252/embj.201694300